| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 22,172 | 21,081 | 26,571 | 34,811 | | Cost of Revenue | 12,048 | 11,025 | 11,862 | 14,277 | | | Gross Profit | 10,124 | 10,057 | 14,709 | 20,534 | | | Operating Expenses | | Research Development | 3,369 | 3,446 | 4,154 | 4,296 | | Selling General and Administrative | 7,211 | 7,670 | 11,659 | 13,084 | | Non Recurring | 1,785 | (855) | (930) | 176,357 | | Others | 1,211 | 1,335 | 2,135 | 3,079 | | | | Total Operating Expenses | 13,577 | 11,596 | 17,018 | 196,815 | | | | Operating Income or Loss | (620) | (1,539) | (2,309) | (176,281) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,846 | 13 | 29 | 88 | | Earnings Before Interest And Taxes | (607) | (1,527) | (2,280) | (176,193) | | Interest Expense | 27 | 32 | 14 | 28 | | Income Before Tax | (634) | (1,558) | (2,294) | (176,221) | | Income Tax Expense | (1,377) | (390) | (621) | (47,771) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 743 | (1,168) | (1,673) | (128,451) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 743 | (1,168) | (1,673) | (128,451) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| (72) | | | Net Income Applicable To Common Shares | $743 | ($1,168) | ($1,673) | ($128,523) |
|
0.02% Nasdaq 
0.99%
Income Statement
